NeuroScientific Biopharmaceuticals Limited (NSB.AX)
AUD 0.04
(5.71%)
AUD 0.04
(5.71%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | - AUD | -100.0% |
| 2023 | 4.95 Million AUD | 0.0% |
| 2022 | - AUD | -100.0% |
| 2021 | 958.76 Thousand AUD | 0.0% |
| 2020 | - AUD | -100.0% |
| 2019 | 33.84 Thousand AUD | 17.22% |
| 2018 | 28.87 Thousand AUD | -24.06% |
| 2017 | 38.02 Thousand AUD | -67.22% |
| 2016 | 116 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | - AUD | 0.0% |
| 2024 Q4 | - AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2023 Q4 | 3.79 Million AUD | 0.0% |
| 2023 FY | 4.95 Million AUD | 0.0% |
| 2023 Q2 | 1.15 Million AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 FY | - AUD | -100.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2021 FY | 958.76 Thousand AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 Q4 | 958.76 Thousand AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2020 FY | - AUD | -100.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2019 Q4 | 33.84 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 FY | 33.84 Thousand AUD | 17.22% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | 28.87 Thousand AUD | -24.06% |
| 2018 Q4 | 28.87 Thousand AUD | 0.0% |
| 2017 FY | 38.02 Thousand AUD | -67.22% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | 38.02 Thousand AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2016 FY | 116 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Anatara Lifesciences Ltd | - AUD | NaN% |
| BTC Health Limited | 16.36 Thousand AUD | 100.0% |
| CSL Limited | 22.41 Billion AUD | 100.0% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 100.0% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 100.0% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 100.0% |
| Orthocell Limited | 5.31 Million AUD | 100.0% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 100.0% |
| Race Oncology Limited | 4 Million AUD | 100.0% |
| Starpharma Holdings Limited | 8.28 Million AUD | 100.0% |
| AdAlta Limited | 1.73 Million AUD | 100.0% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | 100.0% |
| Memphasys Limited | 60 Thousand AUD | 100.0% |
| Acrux Limited | 5.09 Million AUD | 100.0% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | 100.0% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 100.0% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 100.0% |
| Nyrada Inc. | - AUD | NaN% |
| PharmAust Limited | - AUD | NaN% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | 100.0% |
| Arovella Therapeutics Limited | 17 Thousand AUD | 100.0% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 100.0% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 100.0% |
| Biome Australia Limited | 13 Million AUD | 100.0% |
| Biotron Limited | - AUD | NaN% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 100.0% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 100.0% |
| Immutep Limited | 3.5 Million AUD | 100.0% |
| Imugene Limited | - AUD | NaN% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 100.0% |
| Noxopharm Limited | 2.4 Million AUD | 100.0% |
| Patrys Limited | 1.39 Million AUD | 100.0% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 100.0% |
| PYC Therapeutics Limited | 22.05 Million AUD | 100.0% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 100.0% |
| Dimerix Limited | 583.47 Thousand AUD | 100.0% |
| Hexima Limited | - AUD | NaN% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 100.0% |
| Nanollose Limited | 12.5 Thousand AUD | 100.0% |
| Tissue Repair Ltd | 152.24 Thousand AUD | 100.0% |
| AnteoTech Limited | 460.39 Thousand AUD | 100.0% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | 100.0% |
| Recce Pharmaceuticals Ltd | - AUD | NaN% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | 100.0% |
| Actinogen Medical Limited | 9.93 Million AUD | 100.0% |
| Immuron Limited | 4.9 Million AUD | 100.0% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 100.0% |